Clinical Trial Update: A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating DS-6000a in adults with advanced renal cell carcinoma and ovarian cancer; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Renal Cell Carcinoma

Drugs mentioned

• DS-6000a

Snippet

Sponsor: Daiichi Sankyo | Conditions: Renal Cell Carcinoma, Ovarian Tumor | Phase 1 | Status: ACTIVE_NOT_RECRUITING